
==== Front
PeerJ
PeerJ
peerj
PeerJ
2167-8359
PeerJ Inc. San Diego, USA

18151
10.7717/peerj.18151
Biochemistry
Cell Biology
Molecular Biology
Neuroscience
The role of transcriptional and epigenetic modifications in astrogliogenesis
Ma Shuangping 1
Wang Lei 1
Zhang Junhe 1
Geng Lujing 2
Yang Junzheng yangjunzheng606403@163.com
13
1 Institutes of Health Central Plains, Tissue Engineering and Regenerative Clinical Medicine Center, Xinxiang Medical University, Xinxiang, China
2 College of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, China
3 Guangdong Nephrotic Drug Engineering Technology Research Center, The R&D Center of Drug for Renal Diseases, Consun Pharmaceutical Group, Guangzhou, China
Verger Alexis
20 9 2024
2024
12 e1815110 5 2024
31 8 2024
©2024 Ma et al.
2024
Ma et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Astrocytes are widely distributed and play a critical role in the central nervous system (CNS) of the human brain. During the development of CNS, astrocytes provide essential nutritional and supportive functions for neural cells and are involved in their metabolism and pathological processes. Despite the numerous studies that have reported on the regulation of astrogliogenesis at the transcriptional and epigenetic levels, there is a paucity of literature that provides a comprehensive summary of the key factors influencing this process. In this review, we analyzed the impact of transcription factors (e.g., NFI, JAK/STAT, BMP, and Ngn2), DNA methylation, histone acetylation, and noncoding RNA on astrocyte behavior and the regulation of astrogliogenesis, hope it enhances our comprehension of the mechanisms underlying astrogliogenesis and offers a theoretical foundation for the treatment of patients with neurological diseases.

Astrogliogenesis
Transcription factor
DNA methylation
Histone
Astrocyte
National Natural Science Foundation of China82202049 Universities of Henan Province22IRTSTHN030 Key Research and Development and Promotion Special Project of Henan222102310517 This work was supported by the National Natural Science Foundation of China (82202049), the program for Science and Technology Innovation Team in Universities of Henan Province (22IRTSTHN030), and the Key Research and Development and Promotion Special Project of Henan (Scientific and Technological Project) (222102310517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
==== Body
pmcIntroduction

Neuroscience is an active research field with a multitude of fascinating yet unresolved issues. Epigenetics, a discipline that has experienced a period of rapid evolution in recent years, with a focus on phenomena that deviate from the principles of classical Mendelian genetics. This encompasses DNA modifications, RNA interference, and histone modifications, all of which play crucial roles and have propelled substantial advancements in neuroscience, particularly in the investigation of astrogliogenesis. These epigenetic mechanisms exhibit tremendous potential for elucidating the underlying processes of astrogliogenesis.

Astrocytes represent the most widely distributed and largest type of glial cells in the mammalian brain. While neurons are the primary cells responsible for processing information in the brain, astrocytes play a crucial supportive role in this process, for example, by aiding in neuronal migration and sustaining neuronal growth and development. Astrocytes are indispensable for the maturation of the central nervous system (CNS), the maintenance of the blood–brain barrier, the formation of synapses, and the transmission of neurotransmitters (Bayraktar et al., 2014; Holst et al., 2019). During the development of the infant brain, both neurons and astrocytes predominantly originate from neural stem cells. Astrocytes possess numerous long, branching projections that extend outward, giving them a star-like appearance. These projections are capable of establishing contact with neurons, blood vessels, and other glial cells, thereby forming a supportive network throughout the brain and spinal cord (Volterra & Meldolesi, 2005). It is noteworthy that astrocytes in the adult mouse brain display remarkable cellular plasticity, which enables them to be induced into neural progenitor cells that can subsequently generate neurons, astrocytes, and oligodendrocytes (Zhang et al., 2022). The activation of JAK/STAT signaling pathway, which is induced by ciliary neurotrophic factor (CTNF), leukemia inhibitors (LIF), and cytokine family members, has been demonstrated to promote astrogliogenesis (Bonni et al., 1997; Jain et al., 2021; Kaur et al., 2005). Furthermore, the Notch signaling pathway interacts with STAT signaling, particularly during organ development (Hu et al., 2021). The effector molecules of Notch signaling, Hes1 and Hes5, interact with STAT and JAK to promote STAT phosphorylation, thereby accelerating astrogliogenesis (Yoshimatsu et al., 2006). The evidence is increasingly suggestive that bone morphogenetic protein (BMP) signaling plays a role in axon regeneration, neuronal differentiation, synaptic maturation, and astrogliosis by facilitating cytoskeletal assembly, particularly in the context of CNS injury (Akram et al., 2022; Zhong & Zou, 2014). Jiang et al. (2020) demonstrated that exposure to nonylphenol, a stable environmental contaminant, during the perinatal period resulted in an increase in the number of astrocytes and a decrease in oligodendrogenesis in the offspring cerebellum, primarily by activating BMP signaling. The potential for astrocytes to be converted into neurons has been a topic of debate in recent years. Chen’s laboratory has demonstrated that the gene NeuroD1, when delivered using an adeno-associated virus, can efficiently reprogram astrocytes in the grey matter into neurons (Chen et al., 2020; Liu et al., 2020). However, Wang et al. (2021) demonstrated that astrocyte-restricted NeuroD1 is unable to induce astrocyte-to-neuronal cell conversion whether in normal conditions or even after brain injury, using lineage-tracing strategies in vivo.

In addition to transcription factors, DNA epigenetic modifications have been demonstrated to play a crucial role in astrogliogenesis (Albert & Huttner, 2018; Yoon et al., 2018). A study demonstrated that astrocytes derived from the cerebellum and cortex exhibit a fundamental transcriptional and epigenomic program, yet display distinct cellular characteristics. This was revealed through an integrative analysis that included mRNA sequencing (mRNA-Seq), genome-wide DNA methylation sequencing, and Assay for Transposase-Accessible Chromatin using sequencing (ATAC-Seq) (Welle et al., 2021). The DNA methylation and demethylation at CpG dinucleotide sites exert a profound determination of neural stem cell fate. The DNA methyltransferases Dnmt1 and Dnmt3a have been demonstrated to impede the maturation of astrocyte differentiation by methylating astrocyte-specific genes, including GFAP and S100β (He et al., 2020; Urayama et al., 2013).

A review of the role of multiple transcription factors and epigenetic modifications in astrogliogenesis provides a comprehensive perspective on the complex process, facilitating the elucidation of the molecular basis of astrocyte differentiation, the development of novel new therapies for neurodegenerative diseases, and the promotion of the application of astrocytes in regenerative medicine.

Survey methodology

This review comprises a synthesis of the research articles from the past five years in PubMed database, Scopus database, Embase database, ScienceDirect database, and Web of Science database.

Mechanism of Astrogliogenesis at Transcriptional Level

Transcription factors are essential molecules in the regulation of gene expression in eukaryotes. During the development of CNS, neural progenitor cells differentiate into either neuronal cells or glial cells with the differentiation process being guided by transcription factors.

The role of NFI genes in astrogliogenesis

The nuclear factor I (NFI) is a family of transcription factors comprises four members, the four members of the family are NFIA, NFIB, NFIC, and NFIX. These factors regulate glial cell differentiation by controlling the expression of astrocyte markers in the developing CNS (Brun et al., 2018). NFIA, comprising 509 amino acids, has been shown to bind to the DNA sequence 5′-TGGCANNNTGCCA-3′  (Gronostajski, 2000). NFIA expression was enriched in astrocytes and oligodendroglia (Chen et al., 2017). Nfia-deficient mice exhibited abnormal glial cell development and corpus callosum abnormalities (Shu et al., 2003). NFIA expression was induced in the ventricular zone region at embryonic day 11.5 (E11.5) to maintain the pool of Glast-positive glial progenitor cells (Deneen et al., 2006). It facilitated the expression of the astrocyte marker GFAP by directly binding to its promoter (Cebolla & Vallejo, 2006), thereby supporting the notion that NFIA promotes the onset of early astrogliogenesis (Tiwari et al., 2018). Moreover, NFIA and SOX9 complex has been demonstrated to play a pivotal role in the initiation of astrogliogenesis (Kang et al., 2012). The aforementioned studies indicate that NFIA is a crucial and indispensable transcription factor during the process of astroglial progenitors differentiating into astrocytes. NFIB is a transcription factor predominantly localized in astrocytes and neuronal cells (Chen et al., 2017). It has been demonstrated that overexpression of NFIB in human pluripotent stem cells results in the formation of an astrocyte population within a period of two weeks (Canals et al., 2018; Yeon et al., 2021). Furthermore, NFIB-induced astrocytes exhibit physiological functions comparable to those of native astrocytes in vivo, as evidenced by RNA sequencing and cell function analysis (Canals et al., 2018). Huang et al. (2022) elucidated that the introduction of astrocyte-related transcription factors NFIB and SOX9 into chimeric human cerebral organoids (chCOs) accelerates the differentiation rate of induced pluripotent stem cells (iPSCs) into astrocytes. It is noteworthy that NFIB and SOX9 not only accelerate the differentiation of iPSCs into astrocytes, but their combination also enables the reprogramming of fibroblasts into astrocytes (Quist et al., 2022). It can be reasonably deduced that reprogrammed astrocytes, have the great potential to play a pivotal role in maintaining brain homeostasis and addressing various neurological disorders. Furthermore, a study demonstrated that NFIX deletion in mice resulted in delayed development of both neuronal and glial lineages within the cerebellum (Fraser et al., 2017). Neurogenesis within the spinal cord remains normal in NFIX-deficient mice, aspects of terminal astrocytic differentiation are impaired (Matuzelski et al., 2017). It has been suggested that NFIX regulated the downstream of NFIA and NFIB coordinated gliogenesis within the spinal cord (Matuzelski et al., 2017).

The role of JAK/STAT signaling in astrogliogenesis

Leukemia inhibitory factor (LIF) and its receptor (LIFR) have been demonstrated to play a protective role for cells of central nervous system, including neuronal cells, myelin oligodendrocytes, and astrocytes against apoptosis induced by hypoxic-glucose deprivation (Huo, Fan & Wang, 2019). Cytokines such as LIF or CNTF induce the dimerization of LIFR with the co-receptor gp130, leading to the phosphorylation and activation of Janus kinases (JAKs). This signaling pathway is of critical importance for the fate determination of glial lineages during brain development (Bonni et al., 1997). In the hippocampus of LIF-knockout mice, the number of astrocytes expressing GFAP was markedly decreased compared to wild-type mice (Bugga et al., 1998). Additionally, neural precursors in the developing forebrain of mice with reduced expression of LIFR were unable to generate astrocytes expressing GFAP and exhibit blocked neural differentiation (Koblar et al., 1998). Moreover, it was observed that gp130-deficient mice exhibited impaired differentiation of astrocytes (Nakashima et al., 1999a). It was observed that GP130, p-JAK2, and p-STAT3 were downregulated following calycosin treatment in H2O2-induced oxidative injury of spinal astrocytes (Song et al., 2022). This suggests that the repression of the JAK/STAT pathway contributes to the survival of spinal astrocytes. Neurogenin-1 (Ngn1) prevents the differentiation of neural stem cells and progenitor cells (NSCs) into astrocytes by inhibiting the JAK/STAT pathway (Zhao et al., 2015). Additionally, another molecule, neurogenin-2 (Ngn2), has been demonstrated to directly bind to the promoters of several astrocyte-specific genes and suppress their expression independently of STAT activity (Sun et al., 2019). A deficiency in zinc (Zn) has been demonstrated to impede astrogliogenesis during the prenatal period and in the context of developmental processes. This is achieved by affecting the activation of STAT3 signaling via a mechanism of redox regulation (Supasai et al., 2021). The transplantation of NSCs mainly predominantly results in the generation of astrocytes in the injured spinal cord (Barnabe-Heider et al., 2010; Liu et al., 2015; Sabelstrom et al., 2013). Spinal cord injury (SCI) is typically accompanied by the formation of scar tissue, and astrocytes derived from NSCs play a crucial role in limiting the expansion of the scar and preventing further axonal loss. In 2010, Barnabe-Heider et al. (2010) employed genetic fate mapping to ascertain provenance of nascent cells following an adult mouse SCI. The researchers observed that astrocytes and ependymal cells, which are typically restricted in their proliferation in the intact spinal cord, were the primary cell types undergoing proliferation following SCI (Barnabe-Heider et al., 2010). Another noteworthy study demonstrated the presence of Dil-labelled GFAP-expressing cells derived from NSCs in the post-injury period. Moreover, the differentiation of astrocytes derived from NSCs was significantly higher than that of neuronal cells derived from NSCs in the spinal cord (Liu et al., 2015). Zhu et al. (2011) isolated NSCs from the subventricular region of newborn rats and observed that the addition of lithium to the medium resulted in a reduction in the number of astrocytes and inhibited the proliferation of glia-restricted progenitor cells (GRPs). Furthermore, the research demonstrated that lithium inhibited astrogliogenesis by inhibiting STAT3 activation via GSK-3β (Zhu et al., 2011). JAK/STAT signaling, typically activated by cytokines, has been demonstrated to promote astrocyte production, while forced activation of JAK/STAT signaling has been observed to result in precocious astrocyte formation. Conversely, the inhibition of this pathway has been demonstrated to prevent the astrocyte differentiation (He et al., 2005). Wang et al. (2020a) clarified that UCA1 expression was significantly inhibited in rats with temporal lobe epilepsy (TLE) induced by kainic acid (KA). The overexpression of UCA1 in these rats resulted in a prolonged latency period in the Morris water maze assay and a reduction in the number of GFAP-expressing cells in the hippocampus. The co-localization of GFAP-positive cells and p-STAT3-positive cells confirmed that STAT3 activation occurred in astrocytes. UCA1 decreased the expressions of p-JAK1 and p-STAT3, indicating that KA-induced astrocyte activation is inhibited of via the JAK/STAT signaling pathway (Wang et al., 2020a). Moreover, this inhibitory effect was mainly mediated by the JAK/STAT signaling pathway in the temporal lobe epilepsy (Wang et al., 2020a). Furthermore, the blockade of the JAK/STAT3 pathway in reactive astrocytes has been demonstrated to increase the frequency of Huntington’s aggregates, a hallmark of Huntingtin’s disease (Ben Haim et al., 2015). Given the specificity of the JAK/STAT pathway in regulating cell proliferation, neuroinflammation, and astrocyte differentiation, it has become a potential drug target for neurological diseases, such as Alzheimer’s disease (Desai et al., 2020; Jain et al., 2021).

The role of BMP signaling in astrogliogenesis

Bone morphogenetic proteins (BMPs) constitute a family of proteins within the transforming growth factor beta superfamily, and BMP-mediated signaling pathways play a pivotal role in the process of astrogliogenesis (Huang & Xiong, 2016). In the CNS, BMPs facilitate the generation of astrocytes while simultaneously inhibiting the differentiation of oligodendrocyte progenitor cells (OPCs) (Costa et al., 2019). During the early stage of development, BMPs are expressed in the lateral edge of the neural plate and subsequently in the dorsal midline of the neural tube, and this promote dorsal-medial patterning and the development of the ventral forebrain (Gámez, Rodriguez-Carballo & Ventura, 2013; Mehler et al., 1997). BMPs are widely expressed during late development, especially in the hippocampus and cerebral cortex (Gámez, Rodriguez-Carballo & Ventura, 2013; Mehler et al., 1997). Furthermore, YAP signaling is indispensable for the formation of neocortical astrocytes. Huang & Xiong (2016) elucidated that neogenin is necessary for the activation of RhoA by BMP2 and revealed that neogenin promotes the formation of neocortical astrocytes through the cascade reaction of BMP2-Neogenin-YAP-Smad1 cascade reaction (Huang & Xiong, 2016; Wu et al., 2021) (Fig. 1). In BMP4 transgenic mice, an increase in astrocyte density of 40% was observed in several brain regions, while oligodendrocyte density decreased by 11% to 26% (Gomes, Mehler & Kessler, 2003). In a recent study, Lattke et al. (2021) demonstrated that the addition of BMP4 to culture conditions promoted the differentiation of neural stem cells (NSCs) into astrocytes, which is consistent with a previous study in the field. Fibrinogen derived from blood has been demonstrated to significantly enhance astrogliogenesis via the activation of the BMP receptor signaling pathway while simultaneously inhibiting neuronal differentiation in the subventricular zone (SVZ) and hippocampal neural stem cells (NSCs) (Pous et al., 2020). Furthermore, the absence of fibrinogen markedly impairs astrocyte formation following cortical injury (Pous et al., 2020). In addition, simultaneous knockout of BMPR1a and BMPR1b in mice has been shown to reduce the number of mature glial cells in the neural tube by 25% to 40% (See et al., 2007). Introducing TGF-β1 via intraventricular in-utero injection resulted in the disorganization of radial glial fibers and premature gliogenesis with the appearance of GFAP-positive cells (Stipursky et al., 2014).

10.7717/peerj.18151/fig-1 Figure 1 Neural stem cells can differentiate into astrocytes under BMP2-induction.

Briefly, BMP2 promotes p-Smad1/5/8 getting into nuclei in the presence of YAP and activates RhoA assisted by neogenin. Ultimately, BMP2 accelerates astrocyte differentiation without the cooperation of p-Smad1/5/8 signaling and YAP signaling (modified from Huang & Xiong, 2016: Fig. 1).

Other transcription factors in astrogliogenesis

WNT/β-catenin, as a classic transcriptional regulator, plays a pivotal role in maintaining the equilibrium between cell proliferation and differentiation during neurogenesis. Furthermore, its activation results in an increased expression of neurogenin 2 (Ngn2), which in turn disrupts astrogliogenesis in the developing spinal cord (Sun et al., 2019). It is of particular significance that Ngn2, acting as a transcription repressor, directly binds to astrocytic gene promoters, including Fgfr3 and Gfap, and thereby inhibits their transcription, thus impeding astrogliogenesis in the developing spinal cord (Sun et al., 2019) (Fig. 2A). Gan et al. (2014) demonstrated that the deletion of β-catenin in hGFAP-Cre mice inhibited neocortex formation, primarily by disrupting the development of radial glial cells. Furthermore, the JAK-STAT pathway, another classic transcription factor pathway, has also been demonstrated to play a role in astrogliogenesis. For example, Zhao et al. (2015) demonstrated that the molecule Ngn1 binds to the promoter of miR-9 to promote its expression in the brain. miR-9 directly targets key upstream molecules of the JAK-STAT signaling pathway, such as LIFR-β, Il6st (gp130), and Jak1, preventing STAT phosphorylation and ultimately leading to the inhibition of astrogliogenesis (Fig. 2B).

10.7717/peerj.18151/fig-2 Figure 2 Ngn2 and Ngn1 participate in the astrogliogenesis.

(A) WNT/ β-catenin promotes Ngn2 expression by binding to the promoter of Ngn2 via putative TCF/LEF binding sites. Next, increased Ngn2 inhibits astrocytic gene Fgfr3 and Gfap transcription by binding to their promoters, leading to restriction of astrogliogenesis. (B) Ngn1 activates miR-9 expression via promoting its transcription, and mature miR-9 decreases the expression of JAK/STAT upstream molecules, such as LIFR- β, gp130, and Jak1, by binding to their 3′ UTR. ultimately leading to inhibition of astrogliogenesis (modified from Huang & Xiong, 2016: Fig. 1).

The transcription factor zinc finger and BTB domain-containing protein 20 (ZBTB20) is also involved in cell-specific regulation during neocortical development, particularly in the process of astrogliogenesis. The protein is expressed in the proliferative regions of the mouse neocortex during embryonic stages E15 to E18 and is also transiently expressed in projection neurons of the upper cortex during the early postnatal period. In adults, its expression is primarily limited to astrocytes (Mitchelmore et al., 2002; Nagao et al., 2016; Tonchev et al., 2016). Recently, the role of ZBTB20 in modulating astrogliogenesis has been a topic of contention in recent studies. It has been demonstrated that ZBTB20 is highly expressed in late-stage NPCs and their astrocytic progeny. While overexpression of ZBTB20 promoted astrocytogenesis and its knockdown suppressed it, this process was dependent on Sox9 and NFIA, and not through direct activation of the Gfap promoters (Nagao et al., 2016). However, Medeiros de Araújo et al. (2021) demonstrated that in mice in which ZBTB20 was conditionally deleted, the number of astrocyte subsets expressing with SOX9 and GFAP were increased after P10, while the number of S100β+ cells remained unaltered. Furthermore, the expression of Zbtb20 WT at E16.5 was observed to significantly increased the number of S100β+ astrocytes, while the expression of Zbtb20DN (DN: dominant-negative mutation) which is associated with Primrose syndrome (Cordeddu et al., 2014), was found to significantly reduced their number of astrocytes. This was attributed to its impact on the collaboration with other ZBTB family members to regulate astrogliogenesis (Medeiros de Araújo et al., 2021). SOX9 is an important transcription factor that is astrocyte-specific and directly regulates GFAP expression by binding to its promoter (Byun et al., 2020). It facilitates astrogliogenesis by coordinating with NFIA (Kang et al., 2012) and targeting the JAK-STAT and BMP pathways.

Mechanism of Astrogliogenesis at the Epigenetic Level

DNA methylation

DNA methylation represents a crucial epigenetic mechanism in mammalian genomes, whereby alterations in gene expression can be achieved without any modification to the underlying DNA sequences. In bacteria, DNA methylation provides the regulatory basis for host adaptation to various environments and serves as a defense method to protect bacterial DNA from foreign phage DNA (Bhootra et al., 2023; Casadesús & Sánchez-Romero, 2022). This process is catalyzed by a group of enzymes known as DNA methyltransferases (Dnmts), which transfer a methyl group from S-adenosine methionine (SAM) to the fifth carbon of a cytosine residue, resulting in the formation of 5-methylcytosine (5mC) (Moore, Le & Fan, 2013; Nakagawa et al., 2020). It should be noted that DNA methylation is not limited to gene promoters; it also occurs in gene bodies, enhancers, silencers, and transposons (Wang & Xu, 2014). When DNA methylation occurs at gene promoters, it has the potential to modulate gene expression by recruiting proteins involved in gene suppression or by affecting the binding of transcription factors to DNA (Jaenisch & Bird, 2003; Moore, Le & Fan, 2013).

DNA methylation is a key process in the differentiation of astrocytes during the fetal stage of brain development. At E11.5 days, the GFAP promoter, which is bound by STAT3, underwent rapid demethylation in response to STAT3 signaling activation (Takizawa et al., 2001). Over 90% of cells within CNS displayed DNA hypomethylation, which resulted in the enhanced expression of GFAP and S100β. This ultimately resulted in premature astrocyte differentiation in mice with conditional deletion of DNMT1 (Fan et al., 2005). However, the absence of DNA methylation in the GFAP promoter is not sufficient for STAT3 binding to its target sites. The knockout of DNMT1, DNMT3a, and DNMT3b in mouse embryonic stem cells resulted in the complete demethylation on the GFAP promoter region, however, STAT3 was unable to bind to the GFAP promoter to induce GFAP transcription, instead, it induced Socs3 transcription which is another target for the JAK-STAT signaling pathway (Urayama et al., 2013) (Fig. 3), suggesting that hypomethylation in the GFAP promoter containing the STAT3-binding site alone is not sufficient to induce GFAP expression. It is of particular importance to note that the accessibility of STAT3 to the binding site in the GFAP promoter region is a crucial factor in the process of astrogliogenesis. The forced expression of NFIA in NSCs at E11 results in the dissociation of DNMT1 from the GFAP promoter, thereby preventing the late NSCs from replicating the methylation signature on the newly synthesized chain in the daughter cells (MuhChyi et al., 2013; Namihira et al., 2009). In mice with a conditional mutation in Dnmt1, there were approximately 90% of cortical and hippocampal cells from E13.5 in the dorsal forebrain exhibited hypomethylation (Hutnick et al., 2009).

10.7717/peerj.18151/fig-3 Figure 3 Astrocytic gene regulation in astrocyte generation.

MiR-153 inhibits NFIA expression at the transcriptional level and impedes NFIA binds to the distal promoter of GFAP. The activation of STAT3 promotes the hypomethylation of the GFAP promoter. SOX9 directly binding to the GFAP promoter activates GFAP expression and it also can cooperate with NFIA or STAT3 affecting GFAP expression. FGF2 facilitates STAT/CBP complex accessing to GFAP promoter by increasing the level of H3K4me3 in STAT binding sites and inhibiting the level of H3K9me3. HDAC genes compete with the STAT/CBP complex on p300.

Histone modifications

In mammalian genomes, a nucleosome is composed of an octamer consisting of two molecules each of histones H2A, H2B, H3, and H4, with 147 bp DNA wrapped around it (Chong & Gan, 2023). While the core part of the histone in the nucleosome remains relatively uniform, the free N-terminal tails are subject to a range of modifications, including acetylation, methylation, phosphorylation, ubiquitination, and ADP ribosylation. These modifications play a crucial role in influencing the transcriptional activity of genes (Zhang et al., 2021).

The diverse range of histone modifications can either inhibit or activate gene transcription depending on whether they lead to chromatin closure or opening, respectively. This ultimately influences the expression of astrocyte lineage genes. Setdb1 (Eset), a histone H3K9-specific methyltransferase, has been demonstrated to inhibit the gene expression through its interaction with the co-repressor KAPI (Nakagawa et al., 2020). Setdb1 is highly expressed during the early stages of mouse brain development. As Setdb1 expression decreases over time, the level of H3K9 trimethylation also decreases, resulting in dysregulation of the specific neural cell gene expressions (Tan et al., 2012). However, Setdb1 has also been observed to activate the expression of certain non-neural genes, including those related to the astrocyte lineage, thereby promoting the formation of astrocytes (Tan et al., 2012). It has been reported that various chromatin marks engage in crosstalk at regulatory elements in gene expression. Specifically, during the stages of astrogliogenesis, ChIP-seq profiles revealed that the levels of H3K27ac and H3K4me1 are enriched at astroglial genes, including Gfap and Aqp4 (Tiwari et al., 2018). have been demonstrated to impede the process of HDAC genes by regulating the acetylation level of STAT3 and competing with STAT3 for binding to p300 (Zhang et al., 2016). In CKO-Olig1 mice, the loss of HDAC3 has been observed to interfere with neurogenesis and astrocyte development, leading to myelination defects and altered astrocyte responses (Zhang et al., 2016). The STAT-SMAD-p300/CBP complex is essential for the expression of astrocyte-specific gene. Furthermore, it has been demonstrated that STAT and BMP signaling act in a synergistic manner to regulate the astrocyte gene expression (Nakashima et al., 1999b). Histone H3K4me3 is also critical for gene expression regulation, particularly in transcriptional activation. Fibroblast growth factor 2 (FGF2) has been demonstrated to confer the potential for NSCs to differentiate into astrocytes by modifying histone H3 in vitro (Song & Ghosh, 2004). Although FGF2 itself does not induce GFAP expression, it promotes the binding of the STAT/CBP complex to the GFAP promoter by increasing the level of H3K4me3 at STAT binding sites and reducing the level of H3K9me3, thereby enhancing CNTF-induced astrogliogenesis (Song & Ghosh, 2004) (Fig. 3). It has been demonstrated that the MAPK signaling is activated by FGF in the process of cortical development, which is critical to the fate determination of NSCs differentiation into neural cells or astrocytes (Dinh Duong et al., 2019). Hirabayashi & Gotoh (2010) provided the genetic evidence to support the hypothesis that the histone modifications play a role in astrocyte formation. It has been demonstrated that the polycomb protein EZH2 inhibited the premature differentiation of glial cells in neural progenitor cells (Sparmann et al., 2013). This inhibition occurs as a result of EZH2 preventing GFAP expression by interacting with the chromatin helicase DNA-binding protein 4 (CHD4). In CHD4-deficient mice, astrogenesis was enhanced during neocortex development (Sparmann et al., 2013). Additionally, Sher, Boddeke & Copray (2011) reported that EZH2 expression in astrocytes induced dedifferentiation of astrocytes back into neural stem cells (NSCs). Moreover, another epigenetic modification, histone serotonylation, has been identified as a factor in astrocytic Slc22a3-regulated sensory processing (Sardar et al., 2023). The aforementioned studies suggest that the differentiation of neural stem cells (NSCs) into astrocytes, as well as the generation and functional roles of astrocytes, are subject to a number of epigenetic modification processes.

Noncoding RNAs

MicroRNAs (miRNAs) which are approximately 21 nucleotides in length and bind to the 3′  untranslated region (UTR) of target genes, they regulate growth, development, and various cellular processes by promoting the degradation or hindering the translation of these target genes (Krol, Loedige & Filipowicz, 2010; Lu & Rothenberg, 2018). Mounting evidence has demonstrated that miRNAs participate in the regulation of astrogliogenesis at the post-transcriptional level. For example, overexpression of miR-153 in the developing cortex via lentiviral infection resulted in a decrease in astrocytes expressing the bubblegum family member 1 (ACSBG1), while increasing the number of neuronal cells expressing NeuN+ (Tsuyama et al., 2015). The 3′  untranslated regions of NFIA and NFIB containing binding sites for miR-153, and they expressions were downregulated when miR-153 was overexpressed in sensory neurons and telencephalic neurons (Tsuyama et al., 2015). miR-153 targeted NeuroD1 in glial cells and was involved in LPS-induced neuroinflammation through inhibiting the phosphorylation of MAPK signaling (Choi et al., 2022).

miR-124 has been demonstrated to play a pivotal role in the reprogramming of astrocytes into immature neuronal cells. This process is initiated by direct targeting of the RNA-binding protein Zfp36L1 at the post-transcriptional level, which is crucial for the successful reprogramming of these cells. This interaction is associated with ARE-mediated mRNA decay, which subsequently inhibits the neurogenic interaction group of Zfp36L1 (Papadimitriou et al., 2023). In addition to post-transcription regulation, miR-124 contributes to neurogenesis by interacting with polypyrimidine-tract-binding protein (PTBP) to regulate nervous system-specific alternative splicing patterns (Wang et al., 2023). In the agomiR-124 treated SCI model, mRNA sequencing revealed a total of 85 upregulated genes and 80 downregulated genes, of these, Tal1 was identified as a potential target gene of miR-124 that mediated the proliferation and differentiation of neuronal precursor cells (Wang et al., 2020b). In another study, miR-124 overexpression was observed to promote the proliferation and neural differentiation in NSCs, while overexpression of its target gene DLL4 was found to reverse these promotive effects (Jiao et al., 2017). Furthermore, miR-124 has been demonstrated to induce the neuronal generation by acting on endogenous neurogenetic pathways, and the addition of the neurogenic compound ISX9 greatly promoted the differentiation and functional maturation of induced neurons (Papadimitriou et al., 2023). These results implicate that miR-124 facilitates neuronal differentiation by targeting Zfp36L1, PTBP1, Tal1, DLL4, and other mechanisms. The question of whether the RNA-binding protein PTB (also known as PTBP1) can induce astrocytes to differentiate into neurons has the subject of considerable debate in recent times. In 2020, Qian et al. (2020) reported that the depletion of PTBP1 via lentivirus in mouse cortical astrocytes resulted in the conversion of astrocytes into neurons, as evidenced by the expression of pan-neuronal markers Tuj1 and MAP2. Similarly, in the same year, Yang’s laboratory demonstrated that the efficient generation of dopaminergic neurons from Müller glia could be achieved by knocking down PTBP1 using the CRISPR system CasRx (Zhou et al., 2020). However, subsequent studies presented evidence that challenges the hypothesis that PTBP1 can convert astrocytes into neuronal cells. Wang et al. confirmed that in vivo knockdown of PTBP1 did not result in the conversion of resident astrocytes into neurons, as evidenced by lineage tracing strategies (Hoang et al., 2023; Wang et al., 2021). Another two additional studies have also reported that the knockdown or depletion of PTBP1 was unable to convert astrocytes into hippocampal neurons or dopaminergic neurons in Alzheimer’s mouse models or Parkinson’s mouse models, respectively (Chen et al., 2022; Guo et al., 2022). These contrasting results suggest that the consequences of PTBP1 knockout at the genomic level may differ from those of knockdown at the mRNA level. These findings underscore the significance of genetic manipulation, lineage tracing, and gene expression profiling in scientific research.

The brain-specific molecule miR-9/9* (Jung et al., 2012), which directs chromatin remodeling in conjunction with miR-124, targets BAF53a at the post-transcriptional level (Yoo et al., 2009). Overexpression of miR-9/9* and miR-124 in neonatal retinal progenitor cells by electroporation in vivo also affected the cell fate of glial cells, these cells were observed to have reduced the expressions of SOX9 and GS, and increased the level of TUBB3 in the postnatal day 14 retina (Suzuki et al., 2020). It suggests that miR-9/9* and miR-124 tend to induce the differentiation of NSCs and retinal progenitor cells into neuronal cells.

It has been reported that in the members of Let-7 family of miRNAs regulate the timing of glial differentiation. Let-7 plays a pivotal role in the determination of the fate of neural progenitor cells, mainly through the targeting of the chromatin-associated protein HMGA2 (Patterson et al., 2014), which promoted Notch intracellular domain entry into Hes5 promoter and subsequently induced astrogliogenesis (Patterson et al., 2014; Rodríguez-Rivera et al., 2009). Induced deletion of let-7 and miR-125 in glial progenitors inhibits astrocyte differentiation (Shenoy, Danial & Blelloch, 2015). Due to Dgcr8 encodes a key cofactor in miRNA generation, Shenoy, Danial & Blelloch (2015) demonstrated that BMP signaling was not affected in Dgcr8-knockout mice, but that pSTAT signal was significantly impaired astrocyte differentiation. The reexpression of let-7 and miR-125 in glial progenitor cells was observed to significantly rescue the differentiation disorders caused by Dgcr8 defects, and this rescued mechanism was found to be parallel to JAK-STAT signaling activating astrogliogenesis (Shenoy, Danial & Blelloch, 2015). In future studies, it would be interesting to determine how the fusion of the JAK-STAT pathway and miRNA to promote astrocyte formation.

Conclusions and Perspective

In conclusion, this paper provides an overview of the key transcription factors, including NFIA, NFIB, and JAK/STAT signaling, which have been demonstrated to play pivotal roles in directing neural stem cells towards an astrocytic fate. NFIA and NFIB are particularly crucial for astrocyte differentiation, whereas JAK/STAT signaling is activated by cytokines such as LIF and CNTF, which facilitate astrogliogenesis. BMP signaling, represents another crucial pathway, facilitating astrogliogenesis while inhibiting oligodendrocyte differentiation. Additionally, other factors, including WNT/β-catenin, ZBTB20, and microRNAs, have been demonstrated to influence this process, either by promoting or inhibiting astrocyte development. At the epigenetic level, DNA methylation, histone modifications, and noncoding RNAs play crucial roles in regulating gene expression during astrogliogenesis. The action of DNA methyltransferases, such as DNMT1, has been demonstrated to inhibit the astrocyte differentiation by methylating astrocyte-specific gene promoters. Histone modifications, including acetylation, methylation, and ubiquitination, affect chromatin accessibility and, as a consequence, regulate astroglial gene transcription. MicroRNAs, including miR-124, miR-9, and Let-7 family members, facilitate the process by targeting specific transcripts and modulating their expression post-transcriptionally. These molecular mechanisms not only enhance our comprehension of astrogliogenesis but also provide novel perspectives and potential therapeutic avenues for the treatment of neurological diseases. Furthermore, it is anticipated that this will facilitate the application of astrocytes in regenerative medicine. The presence of astrocytes is of significance to diseases that have communication barriers with synapses or axons. Perhaps, astrocytes have great inherently plastic with regard to their capacity to “listening to”, “talking to”, and form memories of neuronal cells. Future research could investigate the interactions between transcription factors and epigenetic modifications in greater depth, elucidating their specific mechanisms of action across a range of disease models. Moreover, the development of targeted therapeutic drugs against these specific points holds considerable promise for offering novel strategies and therapeutic approaches for neurological disorders, including Parkinson’s disease (PD), Alzheimer’s disease (AD), and epilepsy.

Additional Information and Declarations

Competing Interests

Author Contributions

Data Availability

Junzheng Yang is employed by Consun Pharmaceutical Group.

Shuangping Ma conceived and designed the experiments, prepared figures and/or tables, and approved the final draft.

Lei Wang analyzed the data, prepared figures and/or tables, and approved the final draft.

Junhe Zhang conceived and designed the experiments, performed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

Lujing Geng performed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Junzheng Yang conceived and designed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

The following information was supplied regarding data availability:

This is a literature review.
==== Refs
References

Akram et al. (2022) Akram R Anwar H Javed MS Rasul A Imran A Malik SA Raza C Khan IU Sajid F Iman T Sun T Han HS Hussain G 2022 Axonal regeneration: underlying molecular mechanisms and potential therapeutic targets Biomedicines 10 12 3186 10.3390/biomedicines10123186 36551942
Albert & Huttner (2018) Albert M Huttner WB 2018 Epigenetic and transcriptional pre-patterning-an emerging theme in cortical neurogenesis Frontiers in Neuroscience 12 359 10.3389/fnins.2018.00359 29896084
Barnabe-Heider et al. (2010) Barnabe-Heider F Goritz C Sabelstrom H Takebayashi H Pfrieger FW Meletis K Frisen J 2010 Origin of new glial cells in intact and injured adult spinal cord Cell Stem Cell 7 4 470 482 10.1016/j.stem.2010.07.014 20887953
Bayraktar et al. (2014) Bayraktar OA Fuentealba LC Alvarez-Buylla A Rowitch DH 2014 Astrocyte development and heterogeneity Cold Spring Harbor Perspectives in Biology 7 1 a020362 10.1101/cshperspect.a020362 25414368
Ben Haim et al. (2015) Ben Haim L Ceyzeriat K Carrillo-de Sauvage MA Aubry F Auregan G Guillermier M Ruiz M Petit F Houitte D Faivre E Vandesquille M Aron-Badin R Dhenain M Deglon N Hantraye P Brouillet E Bonvento G Escartin C 2015 The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer’s and Huntington’s diseases Journal of Neuroscience 35 6 2817 2829 10.1523/JNEUROSCI.3516-14.2015 25673868
Bhootra et al. (2023) Bhootra S Jill N Shanmugam G Rakshit S Sarkar K 2023 DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective Medical Oncology 40 2 71 10.1007/s12032-022-01943-1 36602616
Bonni et al. (1997) Bonni A Sun Y Nadal-Vicens M Bhatt A Frank DA Rozovsky I Stahl N Yancopoulos GD Greenberg ME 1997 Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway Science 278 5337 477 483 10.1126/science.278.5337.477 9334309
Brun et al. (2018) Brun M Jain S Monckton EA Godbout R 2018 Nuclear factor I represses the notch effector HEY1 in glioblastoma Neoplasia 20 10 1023 1037 10.1016/j.neo.2018.08.007 30195713
Bugga et al. (1998) Bugga L Gadient RA Kwan K Stewart CL Patterson PH 1998 Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor Journal of Neurobiology 36 4 509 524 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-# 9740023
Byun et al. (2020) Byun JS Oh M Lee S Gil JE Mo Y Ku B Kim WK Oh KJ Lee EW Bae KH Lee SC Han BS 2020 The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene Journal of Biological Chemistry 295 39 13677 13690 10.1074/jbc.RA120.013352 32759168
Canals et al. (2018) Canals I Ginisty A Quist E Timmerman R Fritze J Miskinyte G Monni E Hansen MG Hidalgo I Bryder D Bengzon J Ahlenius H 2018 Rapid and efficient induction of functional astrocytes from human pluripotent stem cells Nature Methods 15 9 693 696 10.1038/s41592-018-0103-2 30127505
Casadesús & Sánchez-Romero (2022) Casadesús J Sánchez-Romero MA 2022 DNA Methylation in prokaryotes Advances in Experimental Medicine and Biology 1389 21 43 10.1007/978-3-031-11454-0_2 36350505
Cebolla & Vallejo (2006) Cebolla B Vallejo M 2006 Nuclear factor-I regulates glial fibrillary acidic protein gene expression in astrocytes differentiated from cortical precursor cells Journal of Neurochemistry 97 4 1057 1070 10.1111/j.1471-4159.2006.03804.x 16606365
Chen et al. (2017) Chen KS Harris L Lim JWC Harvey TJ Piper M Gronostajski RM Richards LJ Bunt J 2017 Differential neuronal and glial expression of nuclear factor I proteins in the cerebral cortex of adult mice Journal of Comparative Neurology 525 11 2465 2483 10.1002/cne.24206 28295292
Chen et al. (2022) Chen W Zheng Q Huang Q Ma S Li M 2022 Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease Elife 11 e75636 10.7554/eLife.75636 35535997
Chen et al. (2020) Chen YC Ma NX Pei ZF Wu Z Do-Monte FH Keefe S Yellin E Chen MS Yin JC Lee G Minier-Toribio A Hu Y Bai YT Lee K Quirk GJ Chen G 2020 A neuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion Molecular Therapy 28 1 217 234 10.1016/j.ymthe.2019.09.003 31551137
Choi et al. (2022) Choi HR Ha JS Kim EA Cho SW Yang SJ 2022 MiR-30a-5p and miR-153-3p regulate LPS-induced neuroinflammatory response and neuronal apoptosis by targeting NeuroD1 BMB Reports 55 9 447 452 10.5483/BMBRep.2022.55.9.061 35651331
Chong & Gan (2023) Chong CYY Gan L 2023 Are extraordinary nucleosome structures more ordinary than we thought? Chromosoma 132 3 139 152 10.1007/s00412-023-00791-w 36917245
Cordeddu et al. (2014) Cordeddu V Redeker B Stellacci E Jongejan A Fragale A Bradley TE Anselmi M Ciolfi A Cecchetti S Muto V Bernardini L Azage M Carvalho DR Espay AJ Male A Molin AM Posmyk R Battisti C Casertano A Melis D Van Kampen A Baas F Mannens MM Bocchinfuso G Stella L Tartaglia M Hennekam RC 2014 Mutations in ZBTB20 cause Primrose syndrome Nature Genetics 46 8 815 817 10.1038/ng.3035 25017102
Costa et al. (2019) Costa C Eixarch H Martínez-Sáez E Calvo-Barreiro L Calucho M Castro Z Ortega-Aznar A Ramón YCS Montalban X Espejo C 2019 Expression of bone morphogenetic proteins in multiple sclerosis lesions American Journal of Pathology 189 3 665 676 10.1016/j.ajpath.2018.11.007 30553833
Deneen et al. (2006) Deneen B Ho R Lukaszewicz A Hochstim CJ Gronostajski RM Anderson DJ 2006 The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord Neuron 52 6 953 968 10.1016/j.neuron.2006.11.019 17178400
Desai et al. (2020) Desai RJ Varma VR Gerhard T Segal J Mahesri M Chin K Nonnenmacher E Gabbeta A Mammen AM Varma S Horton DB Kim SC Schneeweiss S Thambisetty M 2020 Targeting abnormal metabolism in Alzheimer’s disease: The Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study Alzheimers Dement 6 1 e12095 10.1002/trc2.12095
Dinh Duong et al. (2019) Dinh Duong TA Hoshiba Y Saito K Kawasaki K Ichikawa Y Matsumoto N Shinmyo Y Kawasaki H 2019 FGF signaling directs the cell fate switch from neurons to astrocytes in the developing mouse cerebral cortex Journal of Neuroscience 39 31 6081 6094 10.1523/JNEUROSCI.2195-18.2019 31175212
Fan et al. (2005) Fan G Martinowich K Chin MH He F Fouse SD Hutnick L Hattori D Ge W Shen Y Wu H Ten Hoeve J Shuai K Sun YE 2005 DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling Development 132 15 3345 3356 10.1242/dev.01912 16014513
Fraser et al. (2017) Fraser J Essebier A Gronostajski RM Boden M Wainwright BJ Harvey TJ Piper M 2017 Cell-type-specific expression of NFIX in the developing and adult cerebellum Brain Structure & Function 222 5 2251 2270 10.1007/s00429-016-1340-8 27878595
Gámez, Rodriguez-Carballo & Ventura (2013) Gámez B Rodriguez-Carballo E Ventura F 2013 BMP signaling in telencephalic neural cell specification and maturation Frontiers in Cellular Neuroscience 7 87 10.3389/fncel.2013.00087 23761735
Gan et al. (2014) Gan Q Lee A Suzuki R Yamagami T Stokes A Nguyen BC Pleasure D Wang J Chen HW Zhou CJ 2014 Pax6 mediates ß-catenin signaling for self-renewal and neurogenesis by neocortical radial glial stem cells Stem Cells 32 1 45 58 10.1002/stem.1561 24115331
Gomes, Mehler & Kessler (2003) Gomes WA Mehler MF Kessler JA 2003 Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment Developmental Biology 255 1 164 177 10.1016/s0012-1606(02)00037-4 12618141
Gronostajski (2000) Gronostajski RM 2000 Roles of the NFI/CTF gene family in transcription and development Gene 249 1-2 31 45 10.1016/s0378-1119(00)00140-2 10831836
Guo et al. (2022) Guo T Pan X Jiang G Zhang D Qi J Shao L Wang Z Xu H Zhao Y 2022 Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer’s mouse models Journal of Neuroscience 42 38 7309 7317 10.1523/JNEUROSCI.1060-22.2022 35944999
He et al. (2005) He F Ge W Martinowich K Becker-Catania S Coskun V Zhu W Wu H Castro D Guillemot F Fan G De Vellis J Sun YE 2005 A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis Nature Neuroscience 8 5 616 625 10.1038/nn1440 15852015
He et al. (2020) He F Wu H Zhou L Lin Q Cheng Y Sun YE 2020 Tet2-mediated epigenetic drive for astrocyte differentiation from embryonic neural stem cells Cell Death Discovery 6 30 10.1038/s41420-020-0264-5 32377393
Hirabayashi & Gotoh (2010) Hirabayashi Y Gotoh Y Epigenetic control of neural precursor cell fate during development Nature Reviews Neuroscience 2010 11 377 388 10.1038/nrn2810 20485363
Hoang et al. (2023) Hoang T Kim DW Appel H Ozawa M Zheng S Kim J Blackshaw S 2023 Ptbp1 deletion does not induce astrocyte-to-neuron conversion Nature 618 7964 E1 E7 10.1038/s41586-023-06066-9 37286658
Holst et al. (2019) Holst CB Brøchner CB Vitting-Seerup K Møllgård K 2019 Astrogliogenesis in human fetal brain: complex spatiotemporal immunoreactivity patterns of GFAP, S100, AQP4 and YKL-40 Journal of Anatomy 235 3 590 615 10.1111/joa.12948 30901080
Hu et al. (2021) Hu X Li J Fu M Zhao X Wang W 2021 The JAK/STAT signaling pathway: from bench to clinic Signal Transduction and Targeted Therapy 6 1 402 10.1038/s41392-021-00791-1 34824210
Huang et al. (2022) Huang S Zhang Z Cao J Yu Y Pei G 2022 Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology Signal Transduction and Targeted Therapy 7 1 176 10.1038/s41392-022-01006-x 35691989
Huang & Xiong (2016) Huang Z Xiong WC 2016 Neogenin-YAP signaling in neocortical astrocytic differentiation Neurogenesis 3 1 e1248735 10.1080/23262133.2016.1248735 28405584
Huo, Fan & Wang (2019) Huo L Fan Y Wang H 2019 Leukemia inhibitory factor receptor is involved in apoptosis in rat astrocytes exposed to oxygen-glucose deprivation Biomed Research International 2019 1613820 10.1155/2019/1613820 30937308
Hutnick et al. (2009) Hutnick LK Golshani P Namihira M Xue Z Matynia A Yang XW Silva AJ Schweizer FE Fan G 2009 DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation Human Molecular Genetics 18 15 2875 2888 10.1093/hmg/ddp222 19433415
Jaenisch & Bird (2003) Jaenisch R Bird A 2003 Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals Nature Genetics 33 Suppl 245 254 10.1038/ng1089 12610534
Jain et al. (2021) Jain M Singh MK Shyam H Mishra A Kumar S Kumar A Kushwaha J 2021 Role of JAK/STAT in the neuroinflammation and its association with neurological disorders Annals of Neurosciences 28 3-4 191 200 10.1177/09727531211070532 35341232
Jiang et al. (2020) Jiang Y You M Li S Xu Y Wang Y 2020 Perinatal exposure to nonylphenol delayed myelination in offspring cerebellum Biochemical Pharmacology 178 114120 10.1016/j.bcp.2020.114120 32589996
Jiao et al. (2017) Jiao S Liu Y Yao Y Teng J 2017 miR-124 promotes proliferation and differentiation of neuronal stem cells through inactivating Notch pathway Cell and Bioscience 7 68 10.1186/s13578-017-0194-y 29238518
Jung et al. (2012) Jung HJ Coffinier C Choe Y Beigneux AP Davies BS Yang SH Barnes 2nd RH Hong J Sun T Pleasure SJ Young SG Fong LG 2012 Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA Proceedings of the National Academy of Sciences of the United States of America 109 7 E423 E431 10.1073/pnas.1111780109 22308344
Kang et al. (2012) Kang P Lee HK Glasgow SM Finley M Donti T Gaber ZB Graham BH Foster AE Novitch BG Gronostajski RM Deneen B 2012 Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis Neuron 74 1 79 94 10.1016/j.neuron.2012.01.024 22500632
Kaur et al. (2005) Kaur N Lu B Monroe RK Ward SM Halvorsen SW 2005 Inducers of oxidative stress block ciliary neurotrophic factor activation of Jak/STAT signaling in neurons Journal of Neurochemistry 92 6 1521 1530 10.1111/j.1471-4159.2004.02990.x 15748169
Koblar et al. (1998) Koblar SA Turnley AM Classon BJ Reid KL Ware CB Cheema SS Murphy M Bartlett PF 1998 Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor Proceedings of the National Academy of Sciences of the United States of America 95 6 3178 3181 10.1073/pnas.95.6.3178 9501236
Krol, Loedige & Filipowicz (2010) Krol J Loedige I Filipowicz W 2010 The widespread regulation of microRNA biogenesis, function and decay Nature Reviews Genetics 11 9 597 610 10.1038/nrg2843
Lattke et al. (2021) Lattke M Goldstone R Ellis JK Boeing S Jurado-Arjona J Marichal N MacRae JI Berninger B Guillemot F 2021 Extensive transcriptional and chromatin changes underlie astrocyte maturation in vivo and in culture Nature Communications 12 1 4335 10.1038/s41467-021-24624-5
Liu et al. (2020) Liu MH Li W Zheng JJ Xu YG He Q Chen G 2020 Differential neuronal reprogramming induced by NeuroD1 from astrocytes in grey matter versus white matter Neural Regeneration Research 15 2 342 351 10.4103/1673-5374.265185 31552908
Liu et al. (2015) Liu Y Tan B Wang L Long Z Li Y Liao W Wu Y 2015 Endogenous neural stem cells in central canal of adult rats acquired limited ability to differentiate into neurons following mild spinal cord injury International Journal of Clinical and Experimental Pathology 8 4 3835 3842 26097566
Lu & Rothenberg (2018) Lu TX Rothenberg ME 2018 MicroRNA Journal of Allergy and Clinical Immunology 141 4 1202 1207 10.1016/j.jaci.2017.08.034 29074454
Matuzelski et al. (2017) Matuzelski E Bunt J Harkins D Lim JWC Gronostajski RM Richards LJ Harris L Piper M 2017 Transcriptional regulation of Nfix by NFIB drives astrocytic maturation within the developing spinal cord Developmental Biology 432 2 286 297 10.1016/j.ydbio.2017.10.019 29106906
Mehler et al. (1997) Mehler MF Mabie PC Zhang D Kessler JA 1997 Bone morphogenetic proteins in the nervous system Trends in Neurosciences 20 7 309 317 10.1016/s0166-2236(96)01046-6 9223224
Medeiros de Araújo et al. (2021) Medeiros de Araújo JA Barão S Mateos-White I Espinosa A Costa MR Gil-Sanz C Müller U 2021 ZBTB20 is crucial for the specification of a subset of callosal projection neurons and astrocytes in the mammalian neocortex Development 148 16 dev196642 10.1242/dev.196642 34351428
Mitchelmore et al. (2002) Mitchelmore C Kjaerulff KM Pedersen HC Nielsen JV Rasmussen TE Fisker MF Finsen B Pedersen KM Jensen NA 2002 Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms. Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia Journal of Biological Chemistry 277 9 7598 7609 10.1074/jbc.M110023200 11744704
Moore, Le & Fan (2013) Moore LD Le T Fan G 2013 DNA methylation and its basic function Neuropsychopharmacology 38 1 23 38 10.1038/npp.2012.112 22781841
MuhChyi et al. (2013) MuhChyi C Juliandi B Matsuda T Nakashima K 2013 Epigenetic regulation of neural stem cell fate during corticogenesis International Journal of Developmental Neuroscience 31 6 424 433 10.1016/j.ijdevneu.2013.02.006 23466416
Nagao et al. (2016) Nagao M Ogata T Sawada Y Gotoh Y 2016 Zbtb20 promotes astrocytogenesis during neocortical development Nature Communications 7 11102 10.1038/ncomms11102
Nakagawa et al. (2020) Nakagawa T Wada Y Katada S Kishi Y 2020 Epigenetic regulation for acquiring glial identity by neural stem cells during cortical development Glia 68 8 1554 1567 10.1002/glia.23818 32163194
Nakashima et al. (1999a) Nakashima K Wiese S Yanagisawa M Arakawa H Kimura N Hisatsune T Yoshida K Kishimoto T Sendtner M Taga T 1999a Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation Journal of Neuroscience 19 13 5429 5434 10.1523/jneurosci.19-13-05429.1999 10377352
Nakashima et al. (1999b) Nakashima K Yanagisawa M Arakawa H Taga T 1999b Astrocyte differentiation mediated by LIF in cooperation with BMP2 FEBS Letters 457 1 43 46 10.1016/s0014-5793(99)00997-7 10486560
Namihira et al. (2009) Namihira M Kohyama J Semi K Sanosaka T Deneen B Taga T Nakashima K 2009 Committed neuronal precursors confer astrocytic potential on residual neural precursor cells Developmental Cell 16 2 245 255 10.1016/j.devcel.2008.12.014 19217426
Papadimitriou et al. (2023) Papadimitriou E Koutsoudaki PN Thanou I Karagkouni D Karamitros T Chroni-Tzartou D Gaitanou M Gkemisis C Margariti M Xingi E Tzartos SJ Hatzigeorgiou AG Thomaidou D 2023 A miR-124-mediated post-transcriptional mechanism controlling the cell fate switch of astrocytes to induced neurons Stem Cell Reports 18 4 915 935 10.1016/j.stemcr.2023.02.009 36963393
Patterson et al. (2014) Patterson M Gaeta X Loo K Edwards M Smale S Cinkornpumin J Xie Y Listgarten J Azghadi S Douglass SM Pellegrini M Lowry WE 2014 let-7 miRNAs can act through notch to regulate human gliogenesis Stem Cell Reports 3 5 758 773 10.1016/j.stemcr.2014.08.015 25316189
Pous et al. (2020) Pous L Deshpande SS Nath S Mezey S Malik SC Schildge S Bohrer C Topp K Pfeifer D Fernández-Klett F Doostkam S Galanakis DK Taylor V Akassoglou K Schachtrup C 2020 Fibrinogen induces neural stem cell differentiation into astrocytes in the subventricular zone via BMP signaling Nature Communications 11 1 630 10.1038/s41467-020-14466-y
Qian et al. (2020) Qian H Kang X Hu J Zhang D Liang Z Meng F Zhang X Xue Y Maimon R Dowdy SF Devaraj NK Zhou Z Mobley WC Cleveland DW Fu XD 2020 Reversing a model of Parkinson’s disease with in situ converted nigral neurons Nature 582 7813 550 556 10.1038/s41586-020-2388-4 32581380
Quist et al. (2022) Quist E Trovato F Avaliani N Zetterdahl OG Gonzalez-Ramos A Hansen MG Kokaia M Canals I Ahlenius H 2022 Transcription factor-based direct conversion of human fibroblasts to functional astrocytes Stem Cell Reports 17 7 1620 1635 10.1016/j.stemcr.2022.05.015 35750047
Rodríguez-Rivera et al. (2009) Rodríguez-Rivera NS Molina-Hernández A Sánchez-Cruz E Escalante-Alcalde D Velasco I 2009 Activated Notch1 is a stronger astrocytic stimulus than leukemia inhibitory factor for rat neural stem cells International Journal of Developmental Biology 53 7 947 953 10.1387/ijdb.092869nr 19378247
Sabelstrom et al. (2013) Sabelstrom H Stenudd M Reu P Dias DO Elfineh M Zdunek S Damberg P Goritz C Frisen J 2013 Resident neural stem cells restrict tissue damage and neuronal loss after spinal cord injury in mice Science 342 6158 637 640 10.1126/science.1242576 24179227
Sardar et al. (2023) Sardar D Cheng YT Woo J Choi DJ Lee ZF Kwon W Chen HC Lozzi B Cervantes A Rajendran K Huang TW Jain A Arenkiel BR Maze I Deneen B 2023 Induction of astrocytic Slc22a3 regulates sensory processing through histone serotonylation Science 380 6650 eade0027 10.1126/science.ade0027 37319217
See et al. (2007) See J Mamontov P Ahn K Wine-Lee L Crenshaw 3rd EB Grinspan JB 2007 BMP signaling mutant mice exhibit glial cell maturation defects Molecular and Cellular Neuroscience 35 1 171 182 10.1016/j.mcn.2007.02.012 17391983
Shenoy, Danial & Blelloch (2015) Shenoy A Danial M Blelloch RH 2015 Let-7 and miR-125 cooperate to prime progenitors for astrogliogenesis EMBO Journal 34 9 1180 1194 10.15252/embj.201489504 25715649
Sher, Boddeke & Copray (2011) Sher F Boddeke E Copray S 2011 Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cells Cell Reprogram 13 1 1 6 10.1089/cell.2010.0052 20979531
Shu et al. (2003) Shu T Butz KG Plachez C Gronostajski RM Richards LJ 2003 Abnormal development of forebrain midline glia and commissural projections in Nfia knock-out mice Journal of Neuroscience 23 1 203 212 10.1523/jneurosci.23-01-00203.2003 12514217
Song & Ghosh (2004) Song MR Ghosh A 2004 FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation Nature Neuroscience 7 3 229 235 10.1038/nn1192 14770186
Song et al. (2022) Song Y Li X Liu X Yu Z Zhang G 2022 Calycosin alleviates oxidative injury in spinal astrocytes by regulating the GP130/JAK/STAT pathway Journal of Oleo Science 71 6 881 887 10.5650/jos.ess21174 35584953
Sparmann et al. (2013) Sparmann A Xie Y Verhoeven E Vermeulen M Lancini C Gargiulo G Hulsman D Mann M Knoblich JA Van Lohuizen M 2013 The chromodomain helicase Chd4 is required for Polycomb-mediated inhibition of astroglial differentiation EMBO Journal 32 11 1598 1612 10.1038/emboj.2013.93 23624931
Stipursky et al. (2014) Stipursky J Francis D Dezonne RS Bérgamo De Araújo AP Souza L Moraes CA AlcantaraGomes FC 2014 TGF-β1 promotes cerebral cortex radial glia-astrocyte differentiation in vivo Frontiers in Cellular Neuroscience 8 393 10.3389/fncel.2014.00393 25484855
Sun et al. (2019) Sun S Zhu XJ Huang H Guo W Tang T Xie B Xu X Zhang Z Shen Y Dai ZM Qiu M 2019 WNT signaling represses astrogliogenesis via Ngn2-dependent direct suppression of astrocyte gene expression Glia 67 7 1333 1343 10.1002/glia.23608 30889310
Supasai et al. (2021) Supasai S Adamo AM Mathieu P Marino RC Hellmers AC Cremonini E Oteiza PI 2021 Gestational zinc deficiency impairs brain astrogliogenesis in rats through multistep alterations of the JAK/STAT3 signaling pathway Redox Biology 44 102017 10.1016/j.redox.2021.102017 34049221
Suzuki et al. (2020) Suzuki F Okuno M Tanaka T Sanuki R 2020 Overexpression of neural miRNAs miR-9/9* and miR-124 suppresses differentiation to Muller glia and promotes differentiation to neurons in mouse retina in vivo Genes Cells 25 11 741 752 10.1111/gtc.12809 32979863
Takizawa et al. (2001) Takizawa T Nakashima K Namihira M Ochiai W Uemura A Yanagisawa M Fujita N Nakao M Taga T 2001 DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain Developmental Cell 1 6 749 758 10.1016/s1534-5807(01)00101-0 11740937
Tan et al. (2012) Tan SL Nishi M Ohtsuka T Matsui T Takemoto K Kamio-Miura A Aburatani H Shinkai Y Kageyama R 2012 Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development Development 139 20 3806 3816 10.1242/dev.082198 22991445
Tiwari et al. (2018) Tiwari N Pataskar A Peron S Thakurela S Sahu SK Figueres-Onate M Marichal N Lopez-Mascaraque L Tiwari VK Berninger B 2018 Stage-specific transcription factors drive astrogliogenesis by remodeling gene regulatory landscapes Cell Stem Cell 23 4 557 571 e558 10.1016/j.stem.2018.09.008 30290178
Tonchev et al. (2016) Tonchev AB Tuoc TC Rosenthal EH Studer M Stoykova A 2016 Zbtb20 modulates the sequential generation of neuronal layers in developing cortex Molecular Brain 9 1 65 10.1186/s13041-016-0242-2 27282384
Tsuyama et al. (2015) Tsuyama J Bunt J Richards LJ Iwanari H Mochizuki Y Hamakubo T Shimazaki T Okano H 2015 MicroRNA-153 regulates the acquisition of gliogenic competence by neural stem cells Stem Cell Reports 5 3 365 377 10.1016/j.stemcr.2015.06.006 26212661
Urayama et al. (2013) Urayama S Semi K Sanosaka T Hori Y Namihira M Kohyama J Takizawa T Nakashima K 2013 Chromatin accessibility at a STAT3 target site is altered prior to astrocyte differentiation Cell Structure and Function 38 1 55 66 10.1247/csf.12034 23439558
Volterra & Meldolesi (2005) Volterra A Meldolesi J 2005 Astrocytes, from brain glue to communication elements: the revolution continues Nature Reviews Neuroscience 6 8 626 640 10.1038/nrn1722 16025096
Wang et al. (2020a) Wang H Yao G Li L Ma Z Chen J Chen W 2020a LncRNA-UCA1 inhibits the astrocyte activation in the temporal lobe epilepsy via regulating the JAK/STAT signaling pathway Journal of Cellular Biochemistry 121 10 4261 4270 10.1002/jcb.29634 31909503
Wang et al. (2020b) Wang J Li H Chen L Dong J Yang J Gong Z Wang B Zhao X 2020b mRNA profiling for miR-124-mediated repair in spinal cord injury Neuroscience 438 158 168 10.1016/j.neuroscience.2020.05.013 32413396
Wang et al. (2021) Wang LL Serrano C Zhong X Ma S Zou Y Zhang CL 2021 Revisiting astrocyte to neuron conversion with lineage tracing in vivo Cell 184 21 5465 5481 e5416 10.1016/j.cell.2021.09.005 34582787
Wang & Xu (2014) Wang R Xu J 2014 Genomic DNA methylation and histone methylation Yi Chuan 36 3 191 199 24846959
Wang et al. (2023) Wang Y Xia Y Kou L Yin S Chi X Li J Sun Y Wu J Zhou Q Zou W Jin Z Huang J Xiong N Wang T 2023 Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson’s disease Neurobiology of Disease 184 106224 10.1016/j.nbd.2023.106224 37433411
Welle et al. (2021) Welle A Kasakow CV Jungmann AM Gobbo D Stopper L Nordström K Salhab A Gasparoni G Scheller A Kirchhoff F Walter J 2021 Epigenetic control of region-specific transcriptional programs in mouse cerebellar and cortical astrocytes Glia 69 9 2160 2177 10.1002/glia.24016 34028094
Wu et al. (2021) Wu Q Miao X Zhang J Xiang L Li X Bao X Du S Wang M Miao S Fan Y Wang W Xu X Shen X Yang D Wang X Fang Y Hu L Pan X Dong H Wang H Wang Y Li J Huang Z 2021 Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF- β signaling Theranostics 11 17 8480 8499 10.7150/thno.60031 34373754
Yeon et al. (2021) Yeon GB Shin WH Yoo SH Kim D Jeon BM Park WU Bae Y Park JY You S Na D Kim DS 2021 NFIB induces functional astrocytes from human pluripotent stem cell-derived neural precursor cells mimicking in vivo astrogliogenesis Journal of Cellular Physiology 236 11 7625 7641 10.1002/jcp.30405 33949692
Yoo et al. (2009) Yoo AS Staahl BT Chen L Crabtree GR 2009 MicroRNA-mediated switching of chromatin-remodelling complexes in neural development Nature 460 7255 642 646 10.1038/nature08139 19561591
Yoon et al. (2018) Yoon KJ Vissers C Ming GL Song H 2018 Epigenetics and epitranscriptomics in temporal patterning of cortical neural progenitor competence Journal of Cell Biology 217 6 1901 1914 10.1083/jcb.201802117 29666150
Yoshimatsu et al. (2006) Yoshimatsu T Kawaguchi D Oishi K Takeda K Akira S Masuyama N Gotoh Y 2006 Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex Development 133 13 2553 2563 10.1242/dev.02419 16728475
Zhang et al. (2016) Zhang L He X Liu L Jiang M Zhao C Wang H He D Zheng T Zhou X Hassan A Ma Z Xin M Sun Z Lazar MA Goldman SA Olson EN Lu QR 2016 Hdac3 interaction with p300 histone acetyltransferase regulates the oligodendrocyte and astrocyte lineage fate switch Developmental Cell 36 3 316 330 10.1016/j.devcel.2016.01.002 26859354
Zhang et al. (2022) Zhang Y Li B Cananzi S Han C Wang LL Zou Y Fu YX Hon GC Zhang CL 2022 A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum Proceedings of the National Academy of Sciences of the United States of America 119 11 e2107339119 10.1073/pnas.2107339119 35254903
Zhang et al. (2021) Zhang Y Sun Z Jia J Du T Zhang N Tang Y Fang Y Fang D 2021 Overview of histone modification Advances in Experimental Medicine and Biology 1283 1 16 10.1007/978-981-15-8104-5_1 33155134
Zhao et al. (2015) Zhao J Lin Q Kim KJ Dardashti FD Kim J He F Sun Y 2015 Ngn1 inhibits astrogliogenesis through induction of miR-9 during neuronal fate specification Elife 4 e06885 10.7554/eLife.06885 26271009
Zhong & Zou (2014) Zhong J Zou H 2014 BMP signaling in axon regeneration Current Opinion in Neurobiology 27 127 134 10.1016/j.conb.2014.03.009 24713578
Zhou et al. (2020) Zhou H Su J Hu X Zhou C Li H Chen Z Xiao Q Wang B Wu W Sun Y Zhou Y Tang C Liu F Wang L Feng C Liu M Li S Zhang Y Xu H Yao H Shi L Yang H 2020 Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice Cell 181 3 590 603 e516 10.1016/j.cell.2020.03.024 32272060
Zhu et al. (2011) Zhu Z Kremer P Tadmori I Ren Y Sun D He X Young W 2011 Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta PLOS ONE 6 9 e23341 10.1371/journal.pone.0023341 21931595
